|Year : 2014 | Volume
| Issue : 4 | Page : 378-384
Lipid correlates of attentional impulsivity in first episode mania: Results from an Indian population
Anjana Rao Kavoor, Daya Ram, Sayantanava Mitra
Department of Psychiatry, Central Institute of Psychiatry, Kanke, Ranchi, Jharkhand, India
|Date of Web Publication||15-Sep-2014|
Dr. Anjana Rao Kavoor
Central Institute of Psychiatry, Kanke, Ranchi - 834 006, Jharkhand
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Attentional/cognitive impulsivity has been demonstrated as being associated with an increased risk for suicide and other self-harming behaviors, along with a more severe course in patients with bipolar disorder. That an alteration of the various serum lipid fractions might be associated with increased impulsivity has been proposed in the past, but evidences are ambiguous and mainly based on western population data. Objective: The present study was aimed to analyze the attentional impulsivity and various serum lipid fractions in bipolar patients, from an Indian perspective. Materials and Methods: At presentation, 60 drug free/naïve first episode Mania patients were rated on the Barratt impulsiveness scale-version 11 and Young Mania Rating Scale; body mass index (BMI) was calculated and blood samples were analyzed for total cholesterol (TC), high density lipoproteins, low density lipoproteins and very low density lipoproteins (VLDL), triglycerides (TG) and apolipoproteins A1 and B. Results: The analysis revealed statistically significant negative correlation and inverse linear relationship between TC, TG, VLDL and BMI with attentional impulsivity. Conclusion: The present study adds to the growing literature on a complex relationship between lipid fractions and attentional impulsivity. The findings present interesting insights into the possible substrates of human behavior at biochemical levels. The implications are many, including a need to introspect regarding the promotion of weight loss and cholesterol reduction programs in constitutionally vulnerable population.
Keywords: Attentional impulsivity, bipolar, body mass index, lipid
|How to cite this article:|
Kavoor AR, Ram D, Mitra S. Lipid correlates of attentional impulsivity in first episode mania: Results from an Indian population. Indian J Psychol Med 2014;36:378-84
|How to cite this URL:|
Kavoor AR, Ram D, Mitra S. Lipid correlates of attentional impulsivity in first episode mania: Results from an Indian population. Indian J Psychol Med [serial online] 2014 [cited 2019 Nov 15];36:378-84. Available from: http://www.ijpm.info/text.asp?2014/36/4/378/140703
| Introduction|| |
The construct of impulsivity is multifaceted, ,, manifest as "actions which are poorly conceived, prematurely expressed, unduly risky or inappropriate to the situation and that often result in undesirable consequences".  Impulsivity, in relation to affective disorders, have been studied extensively and a significantly higher level of impulsivity has been demonstrated in these subjects as compared to a healthy population. ,,,,, Researchers have also found an increased impulsivity in euthymic bipolar patients; , though the acute neurochemical changes in brain probably leads to a particularly overt manifestation of this feature ,, during manic episodes.
The neurobiological basis of this impulsivity has received considerable attention in recent years, in terms of both the anatomical , as well as the neurochemical  foundations. Deficient central serotonergic transmission has been proposed ,, as a biological substrate for impulsivity; and a number of studies in past have suggested serum cholesterol to be a surrogate marker ,, for the same and demonstrated a correlation between serum cholesterol and various measures of impulsivity ,,,,, across psychiatric diagnoses. Studies have discussed the effects of cholesterol on serotonergic function, , through its influence on the function of membrane-bound serotonergic structures by altering membrane fluidity  and reduction in serotonin transporter activity due to their destabilization after cholesterol depletion.  Cholesterol depletion also has been found to result in an impaired functioning of 5-HT1A and 5-HT7 receptors. , Cholesterol is also a major component of lipid rafts, which are of significance in synaptic function;  and thus depletion of cholesterol has been shown to have diffuse effects on not only serotonergic functioning, but also on other neurotransmitter systems, including the excitatory amino acid transport,  gamma-amino butyric acid transmission  and opioid signaling.  A tentative conclusion that can be drawn from studies on this aspect is that the interactions between cholesterol and serotonergic functions are almost certain.
Cholesterol consists of various fractions such as high density lipoproteins (HDL), low density lipoproteins (LDL) and very low density lipoproteins (VLDL). When considering impulsivity as a whole, some studies ,, suggest that the most important lipid fraction is HDL, whereas others , propose total cholesterol (TC) or the LDL fraction to be the important one. The proposal that even the sub-constructs of impulsivity might have different biological underpinning  led to studies exploring the relationship between the former and various cholesterol fractions. , In a study by Troisi  found that in a mixed sample population, attentional impulsivity, as measured on Barratt impulsiveness scale-version 11 (BIS 11) attentional subscale, was the construct negatively correlated with lower cholesterol levels; while Conklin et al.  in their study found a negative correlation between motor impulsivity and omega-3 fatty acid in the body.
Coming back to affective disorders, in these patients disruptions in lipid levels have been demonstrated. Patients with manic disorders have been shown to have a lower cholesterol levels , and some studies have also found an increased triglyceride (TG) level in them; , when compared with matched healthy controls. In the light of ongoing discussion, we might now ask a pertinent question: Can this derangement be affecting the disease manifestations and course as such?
The importance of studying impulsivity in these patients with bipolar disorder (BD) is highlighted by the finding of Jiménez et al.  of it exerting a significant role in cognitive and functional impairment in patients with BD and by Swann et al.  of a higher attentional impulsivity being associated with a more severe course and outcome in them. Hence, considering that a high score on measures of attentional/cognitive impulsivity sub-construct is a demonstrated risk factor for suicide and other self-harming behaviors , and that a higher attentional subscale value in BIS 11 was associated with a more severe course;  patients presenting with low cholesterol, attentional impulsivity and mood symptoms warrant increased clinical attention and surveillance.
The present authors intended to study the relationship between attentional impulsivity, measured using BIS 11; and various serum lipid fractions. Present study tried to circumvent a number of limitations in the past studies. Most of the studies investigating the relationship between cholesterol and impulsivity so far have been conducted in the west. The western diet has a higher fat and lower fiber content,  and the population follows a sedentary life-style; compared with the developing countries. Therefore their generalizability to developing countries is questionable. As evident from their sample characteristics, most of the subjects had a body mass index (BMI) above 23, which is much higher compared with the definition of the Indian standards for normal weight. What happens in the normal, or low normal range of BMI is therefore not clear. The past studies did not adequately control for the effects of other factors, which might have influenced the blood lipid levels, like substance abuse. , In the past, it has been proved that both impulsivity  and cholesterol levels  can be affected by drugs like mood stabilizers. Past studies also failed to control for drug status. ,, Most of the studies until date included patients with diagnosis other than affective disorders, ,, or studied a mixed sample.  They tried to study the manifestations of impulsivity like self-harming behavior, violence or suicidality; but none differentiated between the premeditated and impulsive components of these acts, as suggested by Barratt et al.  None of the studies in past correlated the sub-scales of the BIS 11 in subjects with impulsivity, with the cholesterol fractions, except for one by Troisi.  Finally, only TC, HDL and LDL have been studied in detail; but the other fractions as TG and VLDL were not studied in most. As TG levels are elevated in patients with affective disorders , and that obesity and impulsivity have been found to be linked in some studies, , the past studies have neglected this blood lipid fraction in their assessment of impulsivity.
This is the first study, to the best of our knowledge, investigating the relationship between the various lipid fractions and measures of attentional impulsivity as the basic construct, in a homogenous sample of the first episode mania, in a representative developing-country population and with a modest sample size.
| Materials and Methods|| |
The index study was conducted at a postgraduate teaching hospital and a leading tertiary care referral psychiatric facility in the eastern part of the India. The study population consisted of 60 first episode manic patients diagnosed as per International Classification of Diseases-10 Diagnostic Criteria for Research  criteria, by a psychiatrist having a postgraduate qualification in psychiatry. Subjects were excluded if they had a comorbid neurological disorders or general medical conditions such as diabetes mellitus, liver disease, renal disease, hypertension and thyroid dysfunction etc., if they were taking oral contraceptives and beta blockers, or if they were over 65 years of age, or if they had a past history of cholesterol abnormality.
The socio-demographic data was obtained. Height and weight were recorded using standard scales and BMI was calculated. A sample of 5 ml of venous blood was collected between 8 and 9 in the morning, after the subjects have fasted for 12 h. The blood was analyzed on the same day, within 2 h of collection, during which the sample was stored at room temperature. TC, HDL, LDL, VLDL and Serum TG estimation was done by enzymatic method (using cholesterol esterase, cholesterol oxidase and peroxidase) and apolipoproteins (Apo) A1 and B fractions were measured using immunoturbidometry.
On the same day, young mania rating scale (YMRS) and BIS 11 were applied on the subjects. All the subjects were rated on self-administered BIS 11. BIS 11 is the most commonly used self-report measure for assessing impulsivity in both clinical and research settings. The subscales were introduced into the scale in BIS version 10, in recognition of the multidimensional nature of impulsivity, evident after factor analytic studies. BIS 11 is a further improvement on that with the labeling of "Attentional Impulsiveness" subscale, defined as an inability to focus attention or concentrate.  There are 30 personal statements in the BIS 11, as listed by Patton et al.,  designed to assess general impulsiveness taking into account the multi-factorial nature of the construct. Items are rated from 1 (absent) to 4 (most extreme) and scores range from 30 to 120. The BIS 11 identifies three components of impulsivity. Attentional/cognitive impulsivity is a lack of cognitive persistence with an inability to tolerate cognitive complexity; motor impulsivity is a tendency to act on the spur of the moment; and non-planning impulsivity refers to a lack of sense of the future.
The data was analyzed using the SPSS version 16 (SPSS, Inc., Illinois, USA). The frequency counts of the categorical variables were done; and the mean and standard deviation of the continuous variables were calculated across the sample. Kolmogorov-Smirnov test was used to test the normal distribution of all the cholesterol fraction values. Relationship between the various lipid fractions and score on attentional impulsivity subscale of BIS 11 was investigated in bivariate exploratory analysis using Pearson's correlation. Linear regression analysis was applied on the variables emerging to be significantly correlated with the latter.
| Results|| |
The study sample consisted of 50 male and 10 female subjects (n = 60). Out of the 60, 17 were drug free for at-least one month prior to the date of collection of their blood samples and 43 were drug naïve. 9 had a significant family history of either an affective disorder or a psychotic disorder. The sample mean age was 26.88 ± 7.13 years and the mean BMI (kg/m²) was 18.53 ± 2.40 [Table 1]. All the cholesterol values and BIS scores were normally distributed (Kolmogorov-Smirnov test P > 0.05).
|Table 1: Socio-demographic, clinical and laboratory characteristics of subjects for continuous variables (N=60)|
Click here to view
Bivariate correlation revealed BIS 11 attentional scale scores to correlate negatively and significantly with TC, TG, VLDL and Apo B levels [P < 0.05; [Table 2], indicating that a lower values of these were associated with increased attentional impulsivity. Linear relationship emerged between the attentional score and TC, TG, VLDL (P < 0.05) and BMI (P < 0.01) when we conducted linear regression analysis to explore these associations further and the beta was found to be negative in all cases [Table 3].
|Table 2: Pearson's correlation between lipid values and BIS 11 scores (N = 60, df = 57)|
Click here to view
|Table 3: Linear regression analysis of relation between TC, TG, VLDL, Apo B and BMI; and BIS 11 attentional impulsivity subscale score (dependent variable)|
Click here to view
| Discussion|| |
In the present study, the sample size was modest and constituted of only first episode manic patients. A first hypomanic or manic episode has been considered as a valid construct for predicting BD. , Hence the present study selected only first episode mania patients to obtain a homogenous sample, representative of those with BD; who are relatively free from the confounding effects of prolonged medication (mood stabilizers, antipsychotics and antidepressants), as well as the metabolic effects associated with the disorder itself. ,,,,, The mean YMRS score was found to be 27.93 ± 9.12. A score of <10 on YMRS has been used as a cut-off value in defining euthymic subjects in various studies on bipolar patients. , Hence, all the subjects in the present study were symptomatic at the time of induction.
Troisi  had found a significant negative correlation between TC and score on attentional subscale of BIS 11, especially at the lower end of the TC range (<165 mg/dl). Conklin and Stanford  subdivided the scores on BIS 11 and found a negative and significant correlation between TC and LDL levels and attentional impulsivity, measured on BIS 11. Studies exploring similar psychological constructs using manifestations rather than scores on BIS per se found that TC levels were negatively correlated with executive control and sustained attention  and a lowering cholesterol levels had an adverse effect on cognitive functions.  Pozzi et al.  found lower levels of TC to be a significant predictor of impulsivity and Henderson et al.  reported higher serum LDL cholesterol and a recent increase in TC to be associated with comparatively better memory performance. Chakrabarti et al.  found significantly lower levels of TC and LDL in patients with a history of violent crimes compared with those without, in an Indian sample. Thus, in line with previous studies, the role of TC in impulsivity was reconfirmed by the present authors. We further refined the findings on the role of TC and confirm that attentional impulsivity was associated with a lower TC level. We further propose that these two are linearly related to each other and a lower TC level predicted a higher attentional impulsivity, at least within the cholesterol range of the present study population.
However, the present study did not find a role of LDL in manifestation of attentional impulsivity, as demonstrated by several authors in the past. ,, We hypothesize that this was due to a lack of homogeneity in the past studies in terms of clinical sample, drug status and manifestations and measurements of impulsivity. Conversely, the previous studies do not mention a relation between the VLDL fraction, TG levels and attentional impulsivity, while our study predicts a lower VLDL and TG values those with attentional impulsivity. This is a novel finding and was probably obtained because the association between blood lipids and features of impulsivity varied with the characteristics of the population (food habit, lifestyle etc.).  TGs are the major lipids in fat deposits and are implicated in obesity, diabetes and coronary heart diseases. The VLDLs act as vehicles for carrying TGs from the liver to the extra-hepatic tissues  and an increased TG leads to a higher BMI and obesity. Liao et al.  studied subjects with a psychiatric diagnosis of either Schizo-affective disorder or BD and concluded that TG was found to correlate negatively with violent behavior, though they did not specifically address the issue of impulsivity. Our findings and those of Liao et al.  might be related through a complex mechanism encompassing violence, impulsivity and serotonin function. 
Regarding the role of Apo B in impulsivity, insufficient data exists. In an article in 2004 Chakrabarti et al.  had found a lower Apo B level in Indian males with a history of violent crime compared with those without. However, these authors did not differentiate between premeditated and impulsive violence and hence the results cannot be generalized. We believe this aspect requires future replication and elaboration.
We also found a significant negative correlation between obesity and attentional impulsivity. Troisi  in 2011 measured the BMI and failed to find any significant correlation between BMI and other measures of impulsivity. In that study, the mean BMI was 24.35 ± 4.50 kg/m², whereas in the present study, it is 18.53 ± 2.40 kg/m². Gunstad et al.  studied 408 healthy adults and found that overweight and obese adults with BMI >25 performed poorer on tasks involving executive functioning, when compared to normal weight adults. Nederkoorn et al.  studied impulsivity in Dutch women and found significantly higher impulsivity on behavioral measures, but not on self-report measures, in obese subjects. The mean BMI of the two groups were 39.0 ± 5.3 and 22.5 ± 2.2 respectively, but the cause-effect relationship between obesity and impulsivity was not clarified in this study. A study by Bauer et al.  in 2012 examined the association between BMI and the genetic, neuropsychological and psychiatric indicators of impulsivity in formerly substance abusers and concluded that an elevated BMI is associated with genetic, neurophysiological, psychiatric and psychological indicators of impulsivity. Most of these studies dealt with western population and western life-style which is grossly different from the Indian one. Another important difference was that their subjects had much higher BMI compared to the present study sample. Neither of these studies focused on attentional impulsivity; nor did they examine specifically the relationship between impulsivity and BMI in individuals on the lower side of the BMI range. The mean BMI of our study sample was 18.53 ± 2.40 kg/m², which was much lower than the normal mean BMI of the population of the above mentioned studies. Therefore, we hypothesize that in individuals at the lower end of the BMI range, in whom the blood TG and VLDL levels are also on the lower side; BMI and impulsivity have an inverse relationship. This is in line with the proposal by Kaplan et al.  of an evolutionary rationale, in which a lower fat store would prompt the organism to be more active, vigilant and may be, impulsive and risk taking in order to win in the struggle for survival.
| Limitations|| |
The present study suffered from a number of limitations. The sample size was modest (N = 60), but a bigger sample would have provided with more reliable findings. Secondly, the sample had an underrepresentation of the female gender, urban population and subjects from a more affluent background. Some variables like the exact diet and levels of physical activity, which might affect lipid profiles and obesity and other measurements of obesity, such as the waist-hip ratio were not considered. The study used self-report measures of impulsivity (BIS 11), which depends on individual responses and thus might have been influenced by the affective states of the subjects. The study measured cholesterol levels, which have been hypothesized to be acting as a surrogate marker for omega-3 fatty acids.  A direct measurement of the latter, thus, would have given more robust results.
| Conclusion|| |
The current study demonstrates the presence of significant negative correlation between levels of TC, TG, VLDL, Apo B and BMI; and attentional impulsivity in the first episode mania subjects. These correlations followed a linear curve with a negative slope. This is also the first study, to the best of our knowledge, to report a predictive value for various serum lipid fractions and BMI regarding attentional impulsivity, at least in a population with an average BMI at the lower end of normalcy.
This raises an important question regarding the safety of weight loss and lipid lowering therapies in this clinical population, because "the absence of a significant effect of treatment on non-illness mortality alone does not exclude the possibility of cholesterol reduction having any adverse effects on psychological well-being or quality of life"  and as found in this study, a falling lipid level predicted an increasing attentional impulsivity in them. The study, thus, adds to the growing body of evidence regarding a complex association between serum cholesterol and mental health and may provide a word of caution regarding an increased risk of impulsivity in patients with BD with "unnecessary" lipid lowering attempts; thus proving detrimental to their well-being.
In future, this aspect should be explored further using a larger sample size taking into account objective measures of diet, physical activity levels and include other measures of obesity. The studies in the future also need to apply objective measures of impulsivity, encompassing different techniques, to increase sensitivity and specificity of the measurement. Further, the future studies should also measure omega-3 fatty acid levels in addition to the cholesterol fractions, as suggested by Garland et al. 
| References|| |
|1.||Hinslie L, Shatzky J. Psychiatric Dictionary. New York: Oxford University Press; 1940. |
|2.||Eysenck SB, Eysenck HJ. The place of impulsiveness in a dimensional system of personality description. Br J Soc Clin Psychol 1977;16:57-68. |
|3.||Dickman SJ. Impulsivity and information processing. In: McCown WG, Johnson JL, Shure MB, editors. The Impulsive Client: Theory, Research, and Treatment. Washington D.C.: American Psychological Association; 1993. p. 151-84. |
|4.||Durana JH, Barnes PA. A neurodevelopmental view of impulsivity and its relationship to the superfactors of personality. In: McCown WG, Johnson JL, Shure MB, editors. The Impulsive Client: Theory, Research, and Treatment. Washington D.C.: American Psychological Association; 1993. |
|5.||McElroy SL, Pope HG Jr, Keck PE Jr, Hudson JI, Phillips KA, Strakowski SM. Are impulse-control disorders related to bipolar disorder? Compr Psychiatry 1996;37:229-40. |
|6.||Michaelis BH, Goldberg JF, Davis GP, Singer TM, Garno JL, Wenze SJ. Dimensions of impulsivity and aggression associated with suicide attempts among bipolar patients: A preliminary study. Suicide Life Threat Behav 2004;34:172-6. |
|7.||Swann AC, Pazzaglia P, Nicholls A, Dougherty DM, Moeller FG. Impulsivity and phase of illness in bipolar disorder. J Affect Disord 2003;73:105-11. |
|8.||Swann AC, Birnbaum D, Jagar AA, Dougherty DM, Moeller FG. Acute yohimbine increases laboratory-measured impulsivity in normal subjects. Biol Psychiatry 2005;57:1209-11. |
|9.||Kim SW, Grant JE, Eckert ED, Faris PL, Hartman BK. Pathological gambling and mood disorders: Clinical associations and treatment implications. J Affect Disord 2006;92:109-16. |
|10.||Najt P, Perez J, Sanches M, Peluso MA, Glahn D, Soares JC. Impulsivity and bipolar disorder. Eur Neuropsychopharmacol 2007;17:313-20. |
|11.||Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. Am J Psychiatry 2001;158:1783-93. |
|12.||Gilbert KE, Kalmar JH, Womer FY, Markovich PJ, Pittman B, Nolen-Hoeksema S, et al. Impulsivity in adolescent bipolar disorder. Acta Neuropsychiatr 2011;23:57-61. |
|13.||Harrison AA, Everitt BJ, Robbins TW. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: Interactions with dopaminergic mechanisms. Psychopharmacology (Berl) 1997;133:329-42. |
|14.||Evenden JL. The pharmacology of impulsive behaviour in rats II: The effects of amphetamine, haloperidol, imipramine, chlordiazepoxide and other drugs on fixed consecutive number schedules (FCN 8 and FCN 32). Psychopharmacology (Berl) 1998;138:283-94. |
|15.||Weintraub D. Dopamine and impulse control disorders in Parkinson's disease. Ann Neurol 2008;64 Suppl 2:S93-100. |
|16.||Dalley JW, Everitt BJ, Robbins TW. Impulsivity, compulsivity, and top-down cognitive control. Neuron 2011;69:680-94. |
|17.||Murphy ER, Robinson ES, Theobald DE, Dalley JW, Robbins TW. Contrasting effects of selective lesions of nucleus accumbens core or shell on inhibitory control and amphetamine-induced impulsive behaviour. Eur J Neurosci 2008;28:353-63. |
|18.||Pattij T, Vanderschuren LJ. The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 2008;29:192-9. |
|19.||Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials. BMJ 1990;301:309-14. |
|20.||Muldoon MF, Manuck SB, Mendelsohn AB, Kaplan JR, Belle SH. Cholesterol reduction and non-illness mortality: Meta-analysis of randomised clinical trials. BMJ 2001;322:11-5. |
|21.||Troisi A. Cholesterol in coronary heart disease and psychiatric disorders: Same or opposite effects on morbidity risk? Neurosci Biobehav Rev 2009;33:125-32. |
|22.||Steegmans PH, Fekkes D, Hoes AW, Bak AA, van der Does E, Grobbee DE. Low serum cholesterol concentration and serotonin metabolism in men. BMJ 1996;312:221. |
|23.||Terao T, Nakamura J, Yoshimura R, Ohmori O, Takahashi N, Kojima H, et al. Relationship between serum cholesterol levels and meta-chlorophenylpiperazine-induced cortisol responses in healthy men and women. Psychiatry Res 2000;96:167-73. |
|24.||Vevera J, Fisar Z, Kvasnicka T, Zdenek H, Stárková L, Ceska R, et al. Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatry Res 2005;133:197-203. |
|25.||Buydens-Branchey L, Branchey M, Hudson J, Fergeson P. Low HDL cholesterol, aggression and altered central serotonergic activity. Psychiatry Res 2000;93:93-102. |
|26.||Pozzi F, Troisi A, Cerilli M, Autore AM, Lo Castro C, Ribatti D, et al. Serum cholesterol and impulsivity in a large sample of healthy young men. Psychiatry Res 2003;120:239-45. |
|27.||Conklin SM, Stanford MS. Premeditated aggression is associated with serum cholesterol in abstinent drug and alcohol dependent men. Psychiatry Res 2008;157:283-7. |
|28.||Troisi A. Low cholesterol is a risk factor for attentional impulsivity in patients with mood symptoms. Psychiatry Res 2011;188:83-7. |
|29.||Scanlon SM, Williams DC, Schloss P. Membrane cholesterol modulates serotonin transporter activity. Biochemistry 2001;40:10507-13. |
|30.||Golomb BA, Tenkanen L, Alikoski T, Niskanen T, Manninen V, Huttunen M, et al. Insulin sensitivity markers: Predictors of accidents and suicides in Helsinki Heart Study screenees. J Clin Epidemiol 2002;55:767-73. |
|31.||Papakostas GI, Petersen T, Sonawalla SB, Merens W, Iosifescu DV, Alpert JE, et al. Serum cholesterol in treatment-resistant depression. Neuropsychobiology 2003;47:146-51. |
|32.||Sjögren B, Hamblin MW, Svenningsson P. Cholesterol depletion reduces serotonin binding and signaling via human 5-HT(7(a)) receptors. Eur J Pharmacol 2006;552:1-10. |
|33.||Singh P, Paila YD, Chattopadhyay A. Differential effects of cholesterol and 7-dehydrocholesterol on the ligand binding activity of the hippocampal serotonin(1A) receptor: Implications in SLOS. Biochem Biophys Res Commun 2007;358:495-9. |
|34.||Gil C, Cubí R, Blasi J, Aguilera J. Synaptic proteins associate with a sub-set of lipid rafts when isolated from nerve endings at physiological temperature. Biochem Biophys Res Commun 2006;348:1334-42. |
|35.||Butchbach ME, Tian G, Guo H, Lin CL. Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: Importance for excitatory amino acid transporter localization and function. J Biol Chem 2004;279:34388-96. |
|36.||Sooksawate T, Simmonds MA. Effects of membrane cholesterol on the sensitivity of the GABA(A) receptor to GABA in acutely dissociated rat hippocampal neurones. Neuropharmacology 2001;40:178-84. |
|37.||Huang P, Xu W, Yoon SI, Chen C, Chong PL, Liu-Chen LY. Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells. Biochem Pharmacol 2007;73:534-49. |
|38.||Horsten M, Wamala SP, Vingerhoets A, Orth-Gomer K. Depressive symptoms, social support, and lipid profile in healthy middle-aged women. Psychosom Med 1997;59:521-8. |
|39.||Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 1999;85:275-91. |
|40.||Muldoon MF, Ryan CM, Matthews KA, Manuck SB. Serum cholesterol and intellectual performance. Psychosom Med 1997;59:382-7. |
|41.||Barratt ES, Stanford MS, Kent TA, Felthous A. Neuropsychological and cognitive psychophysiological substrates of impulsive aggression. Biol Psychiatry 1997;41:1045-61. |
|42.||Conklin SM, Harris JI, Manuck SB, Yao JK, Hibbeln JR, Muldoon MF. Serum omega-3 fatty acids are associated with variation in mood, personality and behavior in hypercholesterolemic community volunteers. Psychiatry Res 2007;152:1-10. |
|43.||Cassidy F, Carroll BJ. Hypocholesterolemia during mixed manic episodes. Eur Arch Psychiatry Clin Neurosci 2002;252:110-4. |
|44.||Sagud M, Mihaljevic-Peles A, Pivac N, Jakovljevic M, Muck-Seler D. Platelet serotonin and serum lipids in psychotic mania. J Affect Disord 2007;97:247-51. |
|45.||Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder: Findings from the bipolar disorder center for Pennsylvanians. Bipolar Disord 2005;7:424-30. |
|46.||Fiedorowicz JG, Leon AC, Keller MB, Solomon DA, Rice JP, Coryell WH. Do risk factors for suicidal behavior differ by affective disorder polarity? Psychol Med 2009;39:763-71. |
|47.||Jiménez E, Arias B, Castellví P, Goikolea JM, Rosa AR, Fañanás L, et al. Impulsivity and functional impairment in bipolar disorder. J Affect Disord 2012;136:491-7. |
|48.||Swann AC, Lijffijt M, Lane SD, Steinberg JL, Moeller FG. Increased trait-like impulsivity and course of illness in bipolar disorder. Bipolar Disord 2009;11:280-8. |
|49.||Corruble E, Benyamina A, Bayle F, Falissard B, Hardy P. Understanding impulsivity in severe depression? A psychometrical contribution. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:829-33. |
|50.||Swann AC, Steinberg JL, Lijffijt M, Moeller FG. Impulsivity: Differential relationship to depression and mania in bipolar disorder. J Affect Disord 2008;106:241-8. |
|51.||Camm AJ, Bunce NH. Cardiovascular diseases. In: Kumar P, Clark M, editors. Clinical Medicine. 6 th ed. London: Elsevier Saunders; 2005. p. 725-872. |
|52.||Gabriel A. Changes in plasma cholesterol in mood disorder patients: Does treatment make a difference? J Affect Disord 2007;99:273-8. |
|53.||Gunstad J, Paul RH, Cohen RA, Tate DF, Spitznagel MB, Gordon E. Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr Psychiatry 2007;48:57-61. |
|54.||Bauer LO, Yang BZ, Houston RJ, Kranzler HR, Gelernter J. GABRA2 genotype, impulsivity, and body mass. Am J Addict 2012;21:404-10. |
|55.||World Health Organization: The Tenth Revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10): Diagnostic Criteria for Research. Geneva: WHO; 1993. |
|56.||Stanford MS, Mathias CW, Dougherty DM. Fifty years of the Barratt Impulsiveness Scale: An update and review. Pers Individ Dif 2009;47:385-95. |
|57.||Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol 1995;51: 768-74. |
|58.||Tohen M, Zarate CA Jr, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, et al. The McLean-Harvard First-Episode Mania Study: Prediction of recovery and first recurrence. Am J Psychiatry 2003;160:2099-107. |
|59.||McMurrich S, Sylvia LG, Dupuy JM, Peckham AD, Peters AT, Deckersbach T, et al. Course, outcomes, and psychosocial interventions for first-episode mania. Bipolar Disord 2012;14:797-808. |
|60.||Swartz CM. Albumin decrement in depression and cholesterol decrement in mania. J Affect Disord 1990;19:173-6. |
|61.||Ghaemi SN, Shields GS, Hegarty JD, Goodwin FK. Cholesterol levels in mood disorders: High or low? Bipolar Disord 2000;2:60-4. |
|62.||Atmaca M, Kuloglu M, Tezcan E, Ustundag B, Bayik Y. Serum leptin and cholesterol levels in patients with bipolar disorder. Neuropsychobiology 2002;46:176-9. |
|63.||Leboyer M, Soreca I, Scott J, Frye M, Henry C, Tamouza R, et al. Can bipolar disorder be viewed as a multi-system inflammatory disease? J Affect Disord 2012;141:1-10. |
|64.||Fleck DE, Shear PK, Strakowski SM. Processing efficiency and sustained attention in bipolar disorder. J Int Neuropsychol Soc 2005;11:49-57. |
|65.||Clark L, Kempton MJ, Scarnà A, Grasby PM, Goodwin GM. Sustained attention-deficit confirmed in euthymic bipolar disorder but not in first-degree relatives of bipolar patients or euthymic unipolar depression. Biol Psychiatry 2005;57:183-7. |
|66.||Gendle MH, Spaeth AM, Dollard SM, Novak CA. Functional relationships between serum total cholesterol levels, executive control, and sustained attention. Nutr Neurosci 2008;11:84-94. |
|67.||Wardle J, Rogers P, Judd P, Taylor MA, Rapoport L, Green M, et al. Randomized trial of the effects of cholesterol-lowering dietary treatment on psychological function. Am J Med 2000;108:547-53. |
|68.||Henderson VW, Guthrie JR, Dennerstein L. Serum lipids and memory in a population based cohort of middle age women. J Neurol Neurosurg Psychiatry 2003;74:1530-5. |
|69.||Chakrabarti N, Sinha VK, Sinha BN. A study of lipid profile and apolipoproteins A1 and B: Their relationship to aggression and psychopathology in male patients with psychosis. J Forens Psychiatry Psychol 2004;15:314-24. |
|70.||Troisi A, D'Argenio A. Apolipoprotein A-I/apolipoprotein B ratio and aggression in violent and nonviolent young adult males. J Psychiatr Res 2006;40:466-72. |
|71.||Mayes PA, Botham KM. Lipid transport and storage. In: Murray RK, Granner DK, Mayes PA, editors. Harper's Illustrated Biochemistry. New York: Lange; 2003. |
|72.||Liao PJ, Chen CH, Chan HY, Tan HK, Hsu KH. Serum lipid profile could predict the inception and impacts of violent behaviors among acute psychiatric inpatients. Chang Gung Med J 2012;35:382-91. |
|73.||Nederkoorn C, Smulders FT, Havermans RC, Roefs A, Jansen A. Impulsivity in obese women. Appetite 2006;47:253-6. |
|74.||Kaplan JR, Muldoon MF, Manuck SB, Mann JJ. Assessing the observed relationship between low cholesterol and violence-related mortality. Implications for suicide risk. Ann N Y Acad Sci 1997;836:57-80. |
|75.||Garland MR, Hallahan B, McNamara M, Carney PA, Grimes H, Hibbeln JR, et al. Lipids and essential fatty acids in patients presenting with self-harm. Br J Psychiatry 2007;190:112-7. |
[Table 1], [Table 2], [Table 3]